Sign in

NCT07638982Not yet recruitingPhase 1

Axatilimab + CAR-T for High-Risk Lymphoma

An Open-label, Phase I Trial, With an Expansion Cohort: Macrophage Conditioning to Synergize With CAR-T in High-risk Lymphoma (MAC-SHIFT)

Source: ClinicalTrials.gov · Last updated 16 Oct 2026

Brief summary (registry, in English)

Axatilimab + CAR-T in High-Risk Lymphoma

Status (registry)
Not yet recruiting
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
29 (estimated)
First submitted
5 Jun 2026
Start date
31 Dec 2026
Primary completion date
31 Dec 2028
Lead sponsor
Northside Hospital, Inc.
NCT number
NCT07638982

What you commit to

  • Study type: Interventional · Phase 1
  • Planned participants: 29
  • From 31 Dec 2026 to the primary completion date, 31 Dec 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Allogeneic transplant within 100 days of enrollment

Other illness

  • Second malignancy with a high metastatic potential within 3 years
  • Active CNS involvement. Treated CNS disease is allowed
  • Active HBV or HCV infection.
  • Active uncontrolled infections
  • Known HIV positive status
  • Active acute or chronic graft versus host disease
  • History of acute or chronic pancreatitis
  • History of myositis

Other

  • KPS \<60

Who the study is looking for

  • Age ≥ 18 years
  • Histologically confirmed large B-cell lymphoma
  • Presence of one or more high-risk features
  • Eligible to receive CAR-T according to the FDA label
  • Measurable disease by CT or PET
  • Adequate organ function unless related to lymphoma involvement:
  • Pulse oximetry ≥ 92% on room air
  • Ejection Fraction ≥ 40%
  • ALT/AST \< 5x ULN
  • Bilirubin \< 3 x ULN
  • Calculated or measured creatinine Clearance ≥ 30 mL/min

Age in the registry: 8 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Northside Hospital
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.